Lilly Biologist-Translational Immunology in Indianapolis, Indiana
Title Biologist-Translational Immunology
State / Province Indiana
Workplace Arrangement Local
Company Overview At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our 39,000 employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.
Responsibilities Lilly is looking for an associate level scientist with experience in laboratory based molecular and/or cellular immunological methods to support Immunology Translational Sciences. The primary focus will be in the area of autoimmune but you may have the opportunity to work on other immune diseases like allergy. Our mission is to identify mechanism-relevant pharmacodynamic biomarkers for assets in Lilly’s Immunology pipeline and develop drug tailoring hypotheses that can be assessed in clinical trials. The identification of translational biomarker strategies will utilize samples from human-derived sources. The position offers an extraordinary opportunity to impact the tailoring of Lilly’s autoimmune disease therapies to the most suitable patients based on novel biomarkers. We are looking for individuals who have experience in various bioanalytical techniques (e.g. multiplex cytokine assays, assay development, etc.), human cell manipulation and culture, molecular techniques such as qPCR. We need individuals who can work independently as well as be a motivated team player with the ability to work well with cross-functional colleagues supporting the Lilly immunology portfolio.
Some of your responsibilities will include:
Provide expertise in bioanalytical techniques; including immunological assays (e.g., multiplex bead-based ELISAs, ultra-sensitive ELISA systems (e.g., MSD, Quanterix), in vitro functional assays with primary human cells, PCR and biochemical techniques (western blotting, protein phosphorylation)
Procuring and processing various human tissue samples for analysis
Develop novel assays and explore novel technology platforms
Work with project teams and cross-functional partners to identify and validate human translatable biomarkers, especially related to pharmacodynamic response and generation of tailoring hypothesis to be tested in clinical trials in autoimmune diseases
Record, analyze and communicate scientific data to supervisor/manager and project teams with clear interpretation of results and proposed next steps
Maintain high laboratory standards with regard to quality, safety and general laboratory housekeeping
Excellent written and oral communication skills
Ability to critically interpret data.
Bachelors orMasters degree in Immunology/Cell Biology (or related life sciences discipline) with relevant research or laboratory experience
Qualified candidates must be legally authorized to be employed in the United States. Lilly does not anticipate providing sponsorship for employment visa status (e.g., H-1B or TN status) for this employment position.
Demonstrated research experience in immunology and working knowledge of the immune system.
Experience in a pharmaceutical and/or biotechnology environment
Hands-on experience with multi-parameter flow cytometry.
Experience with PCR/qPCR techniques
Excellent interpersonal skills and team spirit
High proficiency in written and spoken English
Ability to contribute to project teams, with clearly defined critical paths, milestones and timelines
Additional Information Lilly is an EEO/Affirmative Action Employer and does not discriminate on the basis of age, race, color, religion, gender, sexual orientation, gender identity, gender expression, national origin, protected veteran status, disability or any other legally protected status.
Removal Date 12-Oct-2017